Stem cell-derived intestine model mimics innate immune responses

November 29, 2017, Public Library of Science

A stem cell-derived in vitro model displays key small intestine characteristics including innate immune responses, according to a study published November 29, 2017 in the open-access journal PLOS ONE by Ying Chen and David Kaplan from Tufts University, US, and colleagues.

In vitro 3D cell systems, so-called 'organ-on-a-chip', are the focus of intense study, with the hope that they may one day replace animal models in bridging the gap between conventional cell cultures and clinical trials. To be successful, such systems must be engineered to mimic vital organ functions and environment. The authors of the present study used a 3D silk scaffold to cultivate human stem cell-derived small intestine-like 'enteroids', and analyzed the resulting to determine how closely its appearance and function mimicked the small intestine environment in the body.

The researchers found that the in the model had successfully differentiated into a mature epithelium layer with all four of the major intestinal cell types and displayed important small intestine characteristics such as tight junctions, polarized microvilli, and secretion of digestive enzymes. When the system was challenged with E. coli infection, the authors observed significant antibacterial response and upregulation of genes involved in the .

The authors believe that their 3D cell system closely mimics the natural human to gut infection. While the model is greatly simplified compared to the complex small intestine environment, the authors hope that it could be used to study the pathogenesis of , as well as to examine interactions between commensal and pathogenic microbes.

Explore further: Team creates functional, stem-cell-derived small bowel segments

More information: Chen Y, Zhou W, Roh T, Estes MK, Kaplan DL (2017) In vitro enteroid-derived three-dimensional tissue model of human small intestinal epithelium with innate immune responses. PLoS ONE 12(11): e0187880. doi.org/10.1371/journal.pone.0187880

Related Stories

Team creates functional, stem-cell-derived small bowel segments

October 10, 2017
Using human induced pluripotent stem cells (iPSCs), a Massachusetts General Hospital research team has bioengineered functional small intestine segments that, when implanted into rats, were capable of deliver nutrients into ...

Immune cells produce wound healing factor, could lead to new IBD treatment

September 20, 2017
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according ...

New hope for short bowel syndrome

May 4, 2015
Researchers at Children's Hospital Los Angeles have successfully made a small intestine that has the structural and molecular components of a healthy intestine.

The colons of patients with IBS react differently to bacteria

September 5, 2017
The intestinal barrier of patients with the gastrointestinal disease IBS allows bacteria to pass more freely than in healthy people, according to a study led by researchers at Linköping University in Sweden. The study, published ...

Gut response to fluid flow

October 27, 2017
Flow of fluids through the gut, such as milk from an infant's diet, generates a shear stress on cells lining the intestine. Ken Lau, Ph.D., and colleagues have demonstrated that microvilli – finger-like membrane protrusions ...

Small intestine permeable peptides facilitate digestive tract absorption

September 21, 2017
Because biopharmaceuticals are medium- and high-molecular-weight, biologically active macromolecules, they are not easily absorbed by the small intestine, resulting in a bottleneck for oral administration. Now, researchers ...

Recommended for you

How protein fragments could help to tackle the cause of hay fever

July 16, 2018
Imperial researchers are looking to protein fragments to help people build up resistance to grass pollen.

Team explores diabetes drug's ability to treat RSV infection

July 13, 2018
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs' small airways. A multi-disciplinary team of Vanderbilt investigators ...

Testing suggests TORC1 inhibitors can boost immune system in the elderly

July 12, 2018
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...

Biologists discover process that neutralizes tumors

July 10, 2018
Researchers from the University of California San Diego have identified an unexpected mechanism that could help determine whether a cancer patient will respond to immunotherapy.

Mitochondrial DNA in exosomes is the alarm that initiates the antiviral response

July 10, 2018
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have provided valuable information about the defense mechanisms of the immune system during the early stages of the response to pathogens ...

Antibody identifier could speed development of therapies for cancer, other diseases

July 10, 2018
A research team led by a UCLA bioengineer has developed a model to predict the extent to which new laboratory-designed antibodies will be able to combat specific human diseases. This is the first time that a comprehensive ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.